prostate cancer: imrt vs proton - ptcog
TRANSCRIPT
![Page 1: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/1.jpg)
Prostate Cancer: IMRT vs Proton
Jason A. Efstathiou, M.D., D.Phil.
Associate Professor of Radiation Oncology
Massachusetts General Hospital
Harvard Medical School
PTCOG 53
Shanghai, China
June 13, 2014
![Page 2: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/2.jpg)
I treat men with both
We are conducting a RCT
Disclosures
Disclaimer
Advisory Board for Medivation/Astellas and Bayer
![Page 3: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/3.jpg)
![Page 4: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/4.jpg)
January 3, 2012
-Ezekiel Emanuel and Steven Pearson
“It Costs More, but Is It Worth More?”
If you want to know what is wrong with American health care today, exhibit A might be the two
new proton beam treatment facilities the Mayo Clinic has begun building… which could cost
taxpayers billions of dollars for a treatment that, in many cases, appears to be no better than
cheaper alternatives.
There is no convincing evidence that proton beam therapy is as good as — much less better
than — cheaper types of radiation for any one of these cancers. There has not been a single
randomized trial…
…it is crazy medicine and unsustainable public policy.
If the United States is ever going to control our health care costs, we have to demand better evidence
of effectiveness, and stop handing out taxpayer dollars with no questions asked.
![Page 5: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/5.jpg)
“I believe that a comparison after 50,000 or so have already
been treated worldwide with Protons, is simply a political
decision with the heat coming from those doctors who do not
have the Proton capability or have a stake driven in other
treatments and do not want to buy this capability.”
“Since 2001, proton therapy has proven to be the most
effective treatment available for prostate cancer that has not
metastasized”
“A highly sophisticated form of radiation therapy, proton
therapy is so precise to the exact target area — the tumor —
that damage to nearby tissue is virtually non-existent.
Standard radiation therapy directs a beam completely through
the patient’s body, so other tissue gets irradiated as well.”
http://www.prostateblog.com
http://www.ehow.com
http://enidnews.com
Internet Health Information
Shah et al. Int J Radiat Oncol Biol Phys. 2013
![Page 6: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/6.jpg)
Medicare Studies
Yu et al., JNCI 2012
![Page 7: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/7.jpg)
“The sharpness of a surgeon’s knife
The softness of an artist’s brush”
![Page 8: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/8.jpg)
Leff B & Finucane TE JAMA 2008; 299: 1830-1832.
![Page 9: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/9.jpg)
Celebrity treated
New technology and the enthusiasm curve
Time
“I wouldn’t give it to a dog”
“Best thing since
sliced bread”
Technique introduced
Appropriate use
“E
nth
usia
sm”
Courtesy of A. Zietman
![Page 10: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/10.jpg)
Radiation therapy for prostate cancer 1994
Conventional
external beam
![Page 11: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/11.jpg)
Conventional
external beam
Conformal external
beam
High-dose conformal
Brachytherapy
Brachytherapy/external beam
Any of the above with
androgen deprivation
3-D
IMRT
Proton
Ultra-high-dose High dose rate
Low dose rate
SBRT
Cyberknife
Radiation therapy for prostate cancer 2014
![Page 12: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/12.jpg)
How did it come to this?
Local tumor control problem with
radiation therapy in prostate cancer
![Page 13: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/13.jpg)
The solution?
Increase radiation dose
![Page 14: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/14.jpg)
Trial stage n ADT Doses tested
MDACC 2008 T1-3 301 - 70 vs 78Gy (3-D)
PROG 2010 T1-2 393 - 70 vs 79Gy (3-D/P+)
NKI 2008 T1-3 664 -/+ 68 vs 78Gy (3-D)
MRC 2007 T1-3 843 + 64 vs 74Gy (3-D)
Hamilton 2005 T1-3 138 - 66 vs 40+30 (HDR)
High Dose Radiation in Prostate Cancer:
Randomized phase III trials
10-20% benefit in FFBF for 8-10 Gy increase in total dose
![Page 15: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/15.jpg)
PROG 9509: A Randomized Trial of Radiation
Dose in Prostate Cancer1,2
• Latest analysis: Median follow-up 8.9 years
1. Zietman AL, et al. JAMA 2005; 294:1233-1239.
2. Zietman AL, et al. J Clin Oncol 2010; 28:1106-1111.
All patients
![Page 16: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/16.jpg)
PROG
1. Zietman AL, et al. JAMA 2005; 294:1233-1239.
2. Zietman AL, et al. J Clin Oncol 2010; 28:1106-1111.
![Page 17: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/17.jpg)
PROG
1. Zietman AL, et al. JAMA 2005; 294:1233-1239.
2. Zietman AL, et al. J Clin Oncol 2010; 28:1106-1111.
![Page 18: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/18.jpg)
70Gy 79Gy
Urinary obstr/irritn 23.3 24.6
Bowel 7.7 7.9
Sexual 68.2 65.9
Symptom scales
0 = no symptoms
100 = maximal distress/dysfunction
PROG
Talcott JA, et al. JAMA 2010; 303: 1046-1053.
![Page 19: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/19.jpg)
Treated
Volume
Critical
structure
Target Volume
Collimator
2-D radiation – 70-90s
Improved radiation delivery systems:
Hardware and software advances
Prostate
![Page 20: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/20.jpg)
Treated
Volume
Prostate Prostate
Target
Volume
Intensity Modulation – 00s
Treated
Volume
Critical
structure
Target Volume
Collimator
3-D Conformal – 90s
Critical
structure
Improved radiation delivery systems:
Hardware and software advances
![Page 21: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/21.jpg)
Comparative DVHs:
Volume of anterior rectum >70Gy
IMRT – <10%
2-D – 55% 3-D – 30%
![Page 22: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/22.jpg)
Months after radiotherapy
100806040200
Fra
ctio
n f
ree
of
recta
l re
actio
n
1.0
.9
.8
.7
.6
.5
.4
.3
.2
.10.0
≤25% Rectum
>25% Rectum
MDACC 78 Gy Arm Grade ≥2 late rectal toxicity:
Subdivided by percent rectum treated to 70 Gy
p = 0.001
6 yr Rectal
toxicity (2+)
≤25%: 16%
>25%: 46%
Kuban DA, et al. Int J Radiat Oncol Biol Phys 2008; 70: 67-74.
![Page 23: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/23.jpg)
Conformal Radiation in Localized
Prostate Cancer
Royal Marsden Randomized Trial 1999
Proctitis
Grade 1 Grade 2
Conformal (3D) 37% 5%
Conventional (2D) 56% 15%
Dearnaley DP, et al. Lancet 1999 ; 353: 267-272 .
![Page 24: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/24.jpg)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2000 2001 2002 2003 2004 2005 2006 2007 2008
IMRT
3-D CRT
Utilization of IMRT for localized Prostate Cancer: SEER Data
Perc
ent
of
Rad
ioth
era
py
for
Pro
stat
e C
ance
r
Sheets, Goldin, Meyer, et al., JAMA 2012
![Page 25: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/25.jpg)
External beam radiation:
climbing the technological ladder
Conventional
EBRT
3D-conformal
IMRT
Protons
$
$$ $$$$
$$$$$
![Page 26: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/26.jpg)
And now…….proton therapy
Aims:
Better tumor eradication through higher doses
Reduced morbidity
![Page 27: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/27.jpg)
Proton Beam Therapy
• The physics
• The clinical potential
![Page 28: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/28.jpg)
Proton Beam Therapy
• The physics
• The clinical potential
![Page 29: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/29.jpg)
Pristine
Bragg
Peaks of
Selected
Energies
Courtesy of
H. Kooy, Ph.D.
![Page 30: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/30.jpg)
Radiation deposition in tissue for photons vs protons
Wilson RR . Radiology 1946; 47, 487-491.
![Page 31: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/31.jpg)
Proton Beam…a searchlight without a tail
![Page 32: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/32.jpg)
Proton Beam Therapy
• The physics
• The clinical potential
![Page 33: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/33.jpg)
MEDULLOBLASTOMA
PHOTONS
PROTONS
Courtesy T. Yock, N. Tarbell, J. Adams
PHOTONS
PROTONS
![Page 34: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/34.jpg)
Orbital
Rhabdomyosarcoma
Courtesy T. Yock, N. Tarbell, J. Adams Photon Proton
![Page 35: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/35.jpg)
Prostate
IMRT Protons
![Page 36: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/36.jpg)
Excess Radiation Dose:
IMRT vs protons
Efstathiou et al. The Cancer Journal 2009;15:312-8.
![Page 37: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/37.jpg)
Whole body radiation dose: marked
reduction in integral dose
Courtesy of A. Trofimov
brachytherapy
![Page 38: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/38.jpg)
Beam Scanning Technology
![Page 39: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/39.jpg)
Comparative DVHs for IMRT, Protons, and IMPT
Trofimov A et al. Int J Radiat Oncol Biol Phys 2007; 69: 444-453.
![Page 40: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/40.jpg)
Partial Prostate Boost using IMPT
Efstathiou et al. The Cancer Journal 2009;15:312-8.
![Page 41: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/41.jpg)
Anterior fields
Tang et al. Int J Radiat Oncol Biol Phys. 2011.
![Page 42: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/42.jpg)
Vargas et al., IJROBP 2007
Proton vs. IMRT Target Coverage
![Page 43: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/43.jpg)
Vargas et al., IJROBP 2007
Proton vs. IMRT: Rectal Dose
![Page 44: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/44.jpg)
Vargas et al., IJROBP 2007
Proton vs. IMRT Rectal Doses
![Page 45: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/45.jpg)
Mendenhall et al., IJROBP 2014
Patient-Reported QOL:
Proton beam (Univ of Florida)
![Page 46: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/46.jpg)
Yoon et al., IJROBP 2009
Scatter Dose
Distance (cm)
![Page 47: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/47.jpg)
Fontenot et al., IJROBP 2009
Scatter Dose: Risk of Radiation
Associated Second Cancers
![Page 48: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/48.jpg)
Does proton beam carry less morbidity in the
treatment of prostate cancer?
• Despite the theoretical advantages of proton therapy,
studies have yet to prove a clear clinical benefit to
proton therapy compared to IMRT
![Page 49: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/49.jpg)
“The Magic Bullet for Prostate Cancer” (2011)
“The Magic Bullet Falls Short” (2012)
SEER-Medicare studies question proton therapy for
prostate cancer
Sheets et al., JAMA 2012; Kim et al., Eur Urol 2011
![Page 50: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/50.jpg)
SEER-Medicare Studies
Treatment dose data?
Target margins?
Use of image guidance?
Differentiates proton from mixed proton/photon?
Includes >1 proton center?
Differentiate screening colonoscopies from
diagnostic colonoscopies?
Includes patient-reported outcomes?
Potential misclassification bias?
Potential confounding by unrecorded variables?
Lingering questions?
Sheets et al., JAMA 2012; Kim et al., Eur Urol 2011
![Page 51: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/51.jpg)
Medicare Studies
Yu et al., JNCI 2012
![Page 52: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/52.jpg)
Patient Reported Bowel Toxicity
Gray et al. Cancer 2013
-30
-25
-20
-15
-10
-5
0
5
10
0 2 4 6 8 10 12 14 16 18 20 22 24
Sco
re c
han
ge fro
m b
aselin
e
Months
Bowel/Rectal Domain
PBT
IMRT
![Page 53: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/53.jpg)
![Page 54: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/54.jpg)
N=400
Low-Intermediate Risk Prostate Cancer
RANDOMI ZE
Proton Beam
IMRT
79.2 Gy (RBE)
79.2 Gy
Patient-Reported Quality of Life Cost-Effectiveness Physics/Biology
ENDPOINTS
clinicaltrials.gov identifier: NCT01617161
![Page 55: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/55.jpg)
• 58 patients randomized as of May 31, 2014
• Trial now also activated at:
• MD Anderson Cancer Center, Central DuPage Hospital
• Soon to be activated at:
• Washington University in St. Louis, Princeton
Radiation Oncology (includes ProCure New Jersey)
• In process of adding:
• University of Washington, MSKCC
PARTIQoL RCT Update (Prostate Advanced Technologies Investigating Quality of Life)
![Page 56: Prostate Cancer: IMRT vs Proton - PTCOG](https://reader031.vdocuments.mx/reader031/viewer/2022012414/616e028f4bc892548859b976/html5/thumbnails/56.jpg)
• EBRT is a safe and effective treatment, dose escalation improves
cancer control without increasing the risk of serious side-effects
• Proton therapy has physical/dosimetric advantages over IMRT
• Protons can spare normal tissues and avoid the low dose radiation
bath (decrease integral dose)
• Retrospective studies have even shown decreased acute bowel and
urinary morbidity compared to photons
• Second cancer modeling studies suggest benefit over IMRT
• We must continue to invest in and promote scientific innovation and
creativity and develop the evidence to support proton therapy while
looking to decrease its cost
Closing Thoughts